TearLab Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.24
Market Cap
$975.76 K
Shares Outstanding
12.2 M
Public Float
10.94 M

Profile

Address
150 LaTerraza Boulevard
Escondido California 92121
United States
Employees -
Website http://www.tearlab.com
Updated 07/08/2019
TearLab Corp. engages in the development and marketing of lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by testing disease markers in tears at the point-of-care. It also intends to measure the osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease. The company was founded by Benjamin D.

Financials

View All

Elias Vamvakas
Executive Chairman
Joseph Jensen
Chief Executive Officer & Director